Literature DB >> 32856868

Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.

Tokuji Ito1, Hiroji Shinkawa1, Shigekazu Takemura1, Shogo Tanaka1, Takayoshi Nishioka1, Toru Miyazaki1, Atsushi Ishihara1, Shoji Kubo1.   

Abstract

OBJECTIVE: The present study aimed to investigate the impact of preoperative C-reactive protein to albumin (CRP/Alb) ratio on the long-term outcomes of patients with intrahepatic cholangiocarcinoma (ICC).
METHODS: 82 patients who underwent hepatic resection for mass-forming type of ICC were evaluated. The relationship between preoperative CRP/Alb ratio and survival outcomes was investigated.
RESULTS: The optimal cutoff value of CRP/Alb ratio for assessing overall survival (OS) was determined as 0.089. Univariate analysis for recurrence-free survival (RFS) showed that CRP/Alb ratio >0.089, carbohydrate antigen 19-9 (CA 19-9) >37 U/mL, lymph node metastasis, vascular invasion, and multiple tumors were significantly associated with postoperative recurrence. On multivariate analysis, the independent prognostic factors identified were CRP/Alb ratio >0.089 (p < 0.001), lymph node metastasis (p = 0.006), and multiple tumors (p < 0.001). Univariate analysis for OS showed that CRP/Alb ratio >0.089, CA 19-9 >37 U/mL, lymph node metastasis, vascular invasion, multiple tumors, and positive surgical margin were significantly associated with overall death. On multivariate analysis, the independent prognostic factors identified were CRP/Alb ratio >0.089 (p < 0.001), lymph node metastasis (p = 0.01), and multiple tumors (p = 0.005).
CONCLUSION: Preoperative CRP/Alb ratio may predict poor long-term outcomes after hepatic resection in patients with ICC.<br />.

Entities:  

Keywords:  CRP/Alb ratio; Hepatic resection; Intrahepatic cholangiocarcinoma; Prognostic factor

Mesh:

Substances:

Year:  2020        PMID: 32856868      PMCID: PMC7771946          DOI: 10.31557/APJCP.2020.21.8.2373

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  36 in total

Review 1.  Clinical presentation and management of intrahepatic cholangiocarcinoma.

Authors:  O Farges; D Fuks
Journal:  Gastroenterol Clin Biol       Date:  2010-03-04

2.  Serum albumin levels correlate with inflammation rather than nutrition supply in burns patients: a retrospective study.

Authors:  Soshi Ishida; Ichiro Hashimoto; Takuya Seike; Yoshiro Abe; Yutaka Nakaya; Hideki Nakanishi
Journal:  J Med Invest       Date:  2014

3.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

Review 4.  New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms.

Authors:  Masaki Yoshida; Junzo Kudoh; Yukio Homma; Kazuki Kawabe
Journal:  Int J Urol       Date:  2012-01-17       Impact factor: 3.369

Review 5.  C-reactive protein in liver cancer surgery.

Authors:  G Morris-Stiff; D Gomez; K R Prasad
Journal:  Eur J Surg Oncol       Date:  2008-03-19       Impact factor: 4.424

Review 6.  Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review.

Authors:  S Pathak; Q M Nunes; I R Daniels; N J Smart
Journal:  Colorectal Dis       Date:  2014-10       Impact factor: 3.788

7.  Preoperative and postoperative cytokines in patients with cancer.

Authors:  H Nakazaki
Journal:  Cancer       Date:  1992-08-01       Impact factor: 6.860

8.  A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer.

Authors:  Kenya Yamanaka; Etsuro Hatano; Masashi Kanai; Shiro Tanaka; Keiichi Yamamoto; Masato Narita; Hiromitsu Nagata; Takamichi Ishii; Takahumi Machimoto; Kojiro Taura; Shinji Uemoto
Journal:  Int J Clin Oncol       Date:  2013-06-14       Impact factor: 3.402

Review 9.  The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.

Authors:  Hong-Jun Xu; Yan Ma; Fang Deng; Wen-Bo Ju; Xin-Yi Sun; Hua Wang
Journal:  Onco Targets Ther       Date:  2017-06-19       Impact factor: 4.147

10.  Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization.

Authors:  Jan Budczies; Frederick Klauschen; Bruno V Sinn; Balázs Győrffy; Wolfgang D Schmitt; Silvia Darb-Esfahani; Carsten Denkert
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more
  1 in total

1.  The Impact of a Preoperative Staging System on Accurate Prediction of Prognosis in Intrahepatic Cholangiocarcinoma.

Authors:  Hisashi Kosaka; Masaki Ueno; Koji Komeda; Daisuke Hokuto; Hiroya Iida; Fumitoshi Hirokawa; Kosuke Matsui; Mitsugu Sekimoto; Masaki Kaibori
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.